Assessing concordance between patient-reported and investigator-reported CTCAE after proton beam therapy for prostate cancer

Assessing concordance between patient-reported and investigator-reported CTCAE after proton beam therapy for prostate cancer

Purpose: We report acute patient-reported outcomes using CTCAE (PRO-CTCAE) of proton beam radiotherapy for high-risk or unfavorable intermediate-risk prostate cancer in a prospective clinical trial. PRO-CTCAE were correlated with investigator reported-CTCAE (IR-CTCAE) to assess the degree of concord...

Full description

Bibliographic Details
Main Authors: Roman O. Kowalchuk, David Hillman, Thomas B. Daniels, Carlos E. Vargas, Jean-Claude M. Rwigema, William W. Wong, Bradley J. Stish, Amylou C. Dueck, Richard Choo
Format: Article
Language:English
Published: Elsevier 2021-11-01
Series:Clinical and Translational Radiation Oncology
Subjects:
Prostate cancer
Proton beam therapy
Patient-reported outcomes
Toxicity
Online Access:http://www.sciencedirect.com/science/article/pii/S2405630821000811

Internet

http://www.sciencedirect.com/science/article/pii/S2405630821000811

Similar Items